Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RAPP is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
36 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 7 days ago
Red flags: 0
161 filers reported a long position in RAPP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $298.9M | 7.2M | +0.1% |
| TRV GP V, LLC | $261.7M | 6.3M | -12% |
| ARCH Venture Management, LLC | $155.4M | 3.7M | Unchanged |
| Capital International Investors | $121.8M | 2.9M | -5.7% |
| GOLDMAN SACHS GROUP INC | $121.3M | 2.9M | -1.1% |
| BlackRock, Inc. | $112.5M | 2.7M | +7.7% |
| Cormorant Asset Management, LP | $110.7M | 2.7M | -10.1% |
| Sofinnova Investments, Inc. | $79.4M | 1.9M | Unchanged |
| JOHNSON & JOHNSON | $74.4M | 1.8M | Unchanged |
| Polar Capital Holdings Plc | $67M | 1.6M | -2.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.